Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer
      QxMD      Google Scholar   
Citation:
Eur J Cancer vol 201 113914
Year:
2024
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
Alliance-data-source,-external-user
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
3734  
Children:
None
Program:
TRP
Primary Committee:
PPP
Sec. Committees:
   
Pharmas:
Bristol-Myers Squibb, Genentech, and Pfizer  
Grants:
U10CA180821, U10CA180882, UG1CA233163, UG1CA233373, P30CA 014089, U10CA180888, UG1CA180830(SWOG)  
Corr. Author:
 
Authors:
                                                                 
Networks:
CA011, CA136, CAPITAL, LAPS-MN026, LAPS-NC007, LAPS-OH007, MN022, MONTEFIORE, MUSC, NC002, SCOR   
Study
Alliance-A152108
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-80405
Phases:
N/A, 3
Keywords: